Search Results - "Zironi, S"

Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy by Bengala, C., Bettelli, S., Bertolini, F., Sartori, G., Fontana, A., Malavasi, N., Depenni, R., Zironi, S., Del Giovane, C., Luppi, G., Conte, P. F.

Get full text

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial by Bengala, C, Bertolini, F, Malavasi, N, Boni, C, Aitini, E, Dealis, C, Zironi, S, Depenni, R, Fontana, A, Del Giovane, C, Luppi, G, Conte, P

“…Background: Advanced biliary tract carcinoma has a very poor prognosis, with chemotherapy being the mainstay of treatment. Sorafenib, a multikinase inhibitor…”
Get full text

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer by Bertolini, F, Malavasi, N, Scarabelli, L, Fiocchi, F, Bagni, B, Giovane, C Del, Colucci, G, Gerunda, G E, Depenni, R, Zironi, S, Fontana, A, Pettorelli, E, Luppi, G, Conte, P F

“…Background: In patients with colorectal liver metastases (CLM) R0 resection significantly improves overall survival (OS). Methods: In this report, we present…”
Get full text

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy by Bengala, C, Bettelli, S, Bertolini, F, Sartori, G, Fontana, A, Malavasi, N, Depenni, R, Zironi, S, Del Giovane, C, Luppi, G, Conte, P F

“…Background: Epidermal growth factor receptor (EGFR), evaluated by immunohistochemistry, has been shown to have prognostic significance in patients with…”
Get full text

Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma by Cocconi, G., Carlini, P., Gamboni, A., Gasperoni, S., Rodinò, C., Zironi, S., Bisagni, G., Porrozzi, S., Cognetti, F., Di Costanzo, F., Canaletti, R., Ruggeri, E.M., Camisa, R., Pucci, F.

“…Background: 5-Fluorouracil (5-FU), doxorubicin and methotrexate (FAMTX) and cisplatin, epirubicin, leucovorin and 5-FU (PELF) have both been reported to be…”
Get full text

Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition by DEL RIOT, G, ZIRONI, S, VALERIANI, L, MENOZZI, R, BONDI, M, BERTOLINI, M, PICCININI, L, BANZI, M. C, FEDERICO, M

“…Weight gain is a common side effect observed in women undergoing adjuvant chemotherapy for breast cancer. Among possible causes a direct effect of chemotherapy…”
Get full text

Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research by Cocconi, G, Bella, M, Zironi, S, Algeri, R, Di Costanzo, F, De Lisi, V, Luppi, G, Mazzocchi, B, Rodinò, C, Soldani, M

“…The combination of cisplatin, epirubicin, and leucovorin preceding fluorouracil (PELF) includes three novel agents compared with the standard combination of…”
Get more information

Mud volcanoes along the inner deformation front of the Calabrian Arc accretionary wedge (Ionian Sea) by Panieri, G., Polonia, A., Lucchi, R.G., Zironi, S., Capotondi, L., Negri, A., Torelli, L.

“…We present geophysical data integrated with the analysis of well-targeted sediment samples in order to contribute to a better understanding of fluid…”
Get full text

The role of the activation of mTOR pathway in patients with advanced neuroendocrine tumors treated with everolimus by Gelsomino, F., Rossi, G., Spallanzani, A., Bertolini, F., Fontana, A., Tamma, V.A., Zironi, S., Depenni, R., Di Emidio, K., Luppi, G.

Get full text

Everolimus in locally advanced rectal cancer (E-LARC study, Ib): biomarkers evaluation by Fontana, A., Federica, B., Reggiani-Bonetti, L., Pettorelli, E., Noventa, S., Meduri, B., Gelsomino, F., Zironi, S., Spallanzani, A., Mazzeo, E., Maiorana, A., Conte, P., Luppi, G.

Get full text

591PA PHASE IB STUDY OF EVEROLIMUS, 5-FLUOROURACIL (5-FU) AND PELVIC RADIOTHERAPY (RT) AS NEO-ADJUVANT TREATMENT FOR LOCALLY ADVANCED RECTAL CANCER (LARC) by Bertolini, F., Pettorelli, E., Meduri, B., Zironi, S., Fontana, A., Gelsomino, F., Mazzeo, E., Depenni, R., Spallanzani, A., Conte, P.F., Luppi, G.

“…Abstract Aim: The addition of 5FU to preoperative RT increases clinical downsizing and pathological downstaging and optimizes local control but has no…”
Get full text

A Phase Ib Study of Everolimus, 5-Fluorouracil (5-Fu) and Pelvic Radiotherapy (Rt) As Neo-Adjuvant Treatment for Locally Advanced Rectal Cancer (Larc) by Bertolini, F., Pettorelli, E., Meduri, B., Zironi, S., Fontana, A., Gelsomino, F., Mazzeo, E., Depenni, R., Spallanzani, A., Conte, P.F., Luppi, G.

Get full text

Feasibility and effectiveness of a combined individual and psychoeducational group intervention in psychiatric residential facilities: A controlled, non-randomized study by Magliano, Lorenza, Puviani, Marta, Rega, Sonia, Marchesini, Nadia, Rossetti, Marisa, Starace, Fabrizio

“…Abstract This controlled, non-randomized study explored the feasibility of introducing a Combined Individual and Group Intervention (CIGI) for users with…”
Get full text

High-dose folinic acid and fluorouracil with or without ifosfamide is an inactive combination in advanced pancreatic cancer : A randomized phase II study of the Italian Oncology Group for Clinical Research (G.O.I.R.C.) by DI COSTANZO, F, TAGLIAVENTI, M, CARLINI, P, ZIRONI, S, MAZZOCCHI, B, BELLA, M, DONATI, D, ACITO, L, MAGGIAN, P, ANGIONA, S

“…The Italian Oncology Group for Clinical Research (GOIRC) randomized 55 naive patients with advanced pancreatic cancer (APC) between intravenous fluorouracil…”
Get full text

FOLFOX6 as first-line treatment in metastatic gastric cancer: Preliminary results of a phase II trial by Fontana, A., Losi, L., Bertolini, F., Zironi, S., Depenni, R., Malavasi, N., Scarabelli, L., Luppi, G., Conte, P. F.

“…Abstract only…”
Get full text

Locally advanced rectal cancer (LARC): A 12-year experience of multimodality approach by Bertolini, F., Scarabelli, L., Del Giovane, C., Zironi, S., De Marco, G., Fontana, A., Depenni, R., Bertoni, F., Luppi, G., Conte, P. F.

“…Abstract only 607 Background: Main objective of the report is to review retrospectively a 12 years experience of pre-operative chemo-radiotherapy (CRT) in…”
Get full text

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer: Results of a phase II trial and role of PET-CT as early predictor of reponse by Bertolini, F., Malavasi, N., Scarabelli, L., Gerunda, G. E., Colucci, G., Fontana, A., Depenni, R., Zironi, S., Luppi, G., Conte, P. F.

“…Abstract only…”
Get full text

Urinary neopterin in malignant lymphoma by Piccinini, L, Zironi, S, Federico, M, Pini, L A, Luppi, G

“…Urinary neopterin levels were studied in 96 patients with malignant lymphomas. Twenty-eight had Hodgkin's disease and 68 non-Hodgkin's lymphoma. Neopterin…”
Get more information

A phase II trial of sorafenib (SOR) in patients (pts) with advanced cholangiocarcinoma (CC) by Dealis, C., Bertolini, F., Malavasi, N., Zironi, S., Boni, C., Banzi, M., Aitini, E., Cavazzini, G., Luppi, G., Conte, P. F.

“…Abstract only…”
Get full text

Prevention of cisplatin-induced vomiting in patients with cancer. A pilot study with a multiagent protocol by Federico, M, Sabbatini, R, Piccinini, P, Zironi, S, Piccinini, L, Silingardi, V

“…Forty patients receiving a total of 102 courses of cisplatin (CDDP)-based treatment were observed in the present study. The patients received an antiemetic…”
Get more information